Chinese herbal formulation PHY906
Term · Oncology and biomedicine · MLC-T-ONC-012550
An oral traditional Chinese herbal formulation in powder form containing a spray-dried preparation of an aqueous extract from the four herbs Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba and Paeonia lactiflora, with potential immunomodulating and chemoprotective activities, and which may be used as an adjuvant for chemotherapeutic agents. Although the mechanisms of action remain to be fully elucidated, PHY906 possesses a wide range of pharmacological activities such as the enhancement of oral uptake of pharmacologically active agents, inhibition of CYP3A4, modulation of certain pro-inflammatory cytokines, enhanced migration of macrophages and lymphocytes, and the inhibition of expression of matrix metalloproteinase (MMP), nuclear factor kappaB (NF-kB), cyclooxygenase (COX), nitric oxide synthase (NOS), beta-glucuronidase, the neurokinin 1 receptor (NK1R; tachykinin receptor 1; TACR1; substance-P receptor) and the delta-opioid receptor. PHY906 may also enhance the anti-tumor effect of other anti-cancer agents, and may protect the gastrointestinal (GI) mucosa against damage and reduce GI symptoms.
| Identifier | MLC-T-ONC-012550 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | KD018; TCM PHY906 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012550",
"term": "Chinese herbal formulation PHY906",
"field": "Oncology and biomedicine",
"definition": "An oral traditional Chinese herbal formulation in powder form containing a spray-dried preparation of an aqueous extract from the four herbs Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba and Paeonia lactiflora, with potential immunomodulating and chemoprotective activities, and which may be used as an adjuvant for chemotherapeutic agents. Although the mechanisms of action remain to be fully elucidated, PHY906 possesses a wide range of pharmacological activities such as the enhancement of oral uptake of pharmacologically active agents, inhibition of CYP3A4, modulation of certain pro-inflammatory cytokines, enhanced migration of macrophages and lymphocytes, and the inhibition of expression of matrix metalloproteinase (MMP), nuclear factor kappaB (NF-kB), cyclooxygenase (COX), nitric oxide synthase (NOS), beta-glucuronidase, the neurokinin 1 receptor (NK1R; tachykinin receptor 1; TACR1; substance-P receptor) and the delta-opioid receptor. PHY906 may also enhance the anti-tumor effect of other anti-cancer agents, and may protect the gastrointestinal (GI) mucosa against damage and reduce GI symptoms.",
"synonyms": [
"KD018",
"TCM PHY906"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/chinese-herbal-formulation-phy906/"
}
Record 4,719 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.